Immune Agglutination Reagent Kit and Method of Measuring Antigen

a technology of immunoagglutination and reagents, applied in the field of monoclonal antibodies, can solve the problems of insufficient amount of latex aggregates formed and inability to achieve desired absorbance, so as to improve the accuracy of measurement, reduce economic costs, and expand the range of measurement

Inactive Publication Date: 2009-05-07
NISSUI PHARMA
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018]The objective of this invention is to provide a method for measuring antigen based on immune agglutination in order to improve the accuracy of the measurement and to expand the range of measurement. Pretreatment of the specimen is not required and general-purpose automated analytical equipment can be used thus cutting down on economical costs. The objective of this invention is also to provide an immune agglutination reagent kit for use in the method of measuring. In addition to these objectives, this invention provides an immune agglutination reagent kit for measuring the CDT amount within a specimen using efficient immune agglutination, anti-CDT monoclonal antibody for use in the immune agglutination reagent kit, and method for measuring CDT using the immune agglutination reagent kit.
[0035]In the conventional method, carrier particles are separately sensitized by a type of antibody that recognizes different epitopes, and these various sensitized carrier particles are then mixed together in just proportions to form an immune agglutination reagent. In allowing agglutination to occur with this reagent, the amount of latex aggregates formed may be inadequate due to the number of epitopes in the antigen being low or due to steric hindrance caused by various epitopes being close to each other. As a result, the desired absorbance may not be achieved. When the kit in the invention containing two types of sensitized carrier particles that are independently preserved is used and one type of reagent is made to react with the specimen suspected to contain antigen and then the other type of reagent is made to react with the reaction solution, agglutination is formed and a substantial change in absorbance can be attained. Measuring antigen in the specimen is thus made possible.

Problems solved by technology

In allowing agglutination to occur with this reagent, the amount of latex aggregates formed may be inadequate due to the number of epitopes in the antigen being low or due to steric hindrance caused by various epitopes being close to each other.
As a result, the desired absorbance may not be achieved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune Agglutination Reagent Kit and Method of Measuring Antigen
  • Immune Agglutination Reagent Kit and Method of Measuring Antigen
  • Immune Agglutination Reagent Kit and Method of Measuring Antigen

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of a Native and Natural CDT Fraction

[0047]An iron saturated solution (250 μl of 0.5M NaHCO3 and 180 μl of 10 mM FeCl3) was added to 10 mL of a high-level CDT human serum and incubated for an hour at 4° C. A delipidated solution (100 μl of 100 g / l sulfuric dextran and 500 μl of 1M CaCl2) was then added and the supernatant of the solution was collected. In addition, the albumin was removed using Blue Sepharose column (Product name: Blue Sepharose 6 Fast Flow; manufactured by GE Healthcare) followed by the removal of globulin using a Protein G column (Product name: Hi Trap Protein G HP, manufactured by GE Healthcare) to ultimately remove all proteins besides transferrin. CDT fraction containing native disialo-transferrin and asialo transferrin was prepared by using an anion-exchange column (Product name: Mono Q HR; manufactured by GE Healthcare).

[0048]FIG. 1 shows a graph of the CDT fraction elution profile by anion-exchange chromatography. Arrow A in the Drawing shows the ...

example 2

Preparation of Hybridoma

[0049]The fraction containing disialo- and asialo-transferrin obtained in the above Example 1 was used as a CDT antigen. The antigen solution with a concentration of 0.5 mg / mL was prepared from the CDT antigen. 500 μl adjuvant (Product name: TiterMax Gold; manufactured by TiterMax Co.) was mixed in with 500 μl of antigen solution and then emulsified. This was used to subcutaneously immunize a 5-week old BALB / c mouse. Three cycles of booster using the same prepared solution was performed with 2 weeks in between cycles. During this period, a blood sample was taken at the time of immunization to measure antibody activity in the blood. 14 days after the last immunization, 100 μl of antigen solution was administered into the abdominal cavity and 3 days later the spleen was extracted. Splenic cells were made to react for 2 min. in the presence of mouse myeloma cells (P3x63Ag8.653) and polyethylene glycol 4000 (Product name; Merck Inc.) for fusion to occur after whi...

example 3

Selection of Antibody Producing Hybridoma for CDT Fraction

[0050]With regards to hybridoma obtained in the above Example 2, selection of antibody producing hybridoma of this invention was done by sandwich ELISA. Anti mouse antibody adjusted to a 10 μg / mL with PBS was added to a 96-well microplate, 50 μl per well, and made to react all day and night at 4° C. The wells were then washed once with PBS and blocked with 0.5% BSA-PBS to be used as the plate for screening. 50 μl of culture supernatant from wells with confirmed hybridoma growth was added to the wells and made to react for 1 hour at room temperature. After washing with wash solution (0.05% Tween-PBS), the CDT fraction mentioned above in Example 1 is made to react for 1 hour at room temperature and similarly washed. A 50 μl alkaline phosphatase labeled anti-transferrin polyclonal antibody is then added and made to react for 1 hour at room temperature. The alkaline phosphatase labeled anti-transferrin polyclonal antibody used wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

In cases of poor reaction efficiency with the antibody due to inadequate number of epitopes or steric hindrance caused by epitopes being close to each other, this invention provides a direct method of efficiently measuring antigen in a given specimen without the need of pretreating it. Two types of monoclonal antibodies that recognize different epitopes are individually sensitized on separate latex. The specimen and one latex sensitized monoclonal antibody reagent are reacted to produce a reaction solution which is then reacted with the other latex sensitized monoclonal antibody reagent. The antigen can thus be directly measured in an efficient and highly sensitive way without pretreating it.

Description

TECHNICAL FIELD[0001]The invention incorporates two types of monoclonal antibodies that recognize different epitopes. It pertains to an immune agglutination reagent kit and method of measuring antigen that enables the accurate measurement of a specific antigen in a specimen by a simple process.BACKGROUND ART[0002]Immunoassay method using antigen-antibody reaction has an important role in the clinical diagnosis of various endocrine diseases. To date, a wide variety of immunoassay methods have been known.[0003]Among them, there is the method of measuring antigen in a specimen using an immune agglutination reagent formed by antibodies sensitized on carrier particles. The immune agglutination reagent is made to react with the antigen in the test substance.[0004]After adding the reagent to the agglutination formed as a result of this antigen antibody reaction, the amount of change in absorbance is measured and compared with that of a known standard serum concentration to determine the fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/566C07K16/18
CPCG01N33/543C07K16/18
Inventor MATSUBAYASHI, TADASHITERUNUMA, IKUOTAKANO, AKINORI
Owner NISSUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap